Member Info for Frankseluk2

Scramble to produce Covid-19 jabs derails supply of regular drugs in the US.
Huge delays. There is a 12-18month waiting list for new orders of glass vials.
The shortage is affecting almost every type of injectable drug in the US, including chemotherapy, insulin and other medicines.
Catalan, a contract manufacturer working for Moderna and Johnson & Johnson, is also prioritising large orders for jabs over other treatments, meaning thousands of patients have had to do without some treatments. Huge scramble for ingredients, equipment or space on production lines.
Catalan has show double digit growth last 3 quarters, q4 20 16.87% q1 21 17.63% q2 21 12.87%.
If that is what a billion dollar company can do just consider what a smaller more nimble company may achieve!
It also highlights the demand there is for other non Covid medical supplies. Involved in Covid or not, demand for other medical supplies is becomming acute.
Thought may be of interest. Not a recommendation, dyor.

Shares jump by £0.10p not a £1.
Even got that wrong.
But the message is the same.
Sorry...

I believe we supply kit to Vectura (inhaler)
If they are a signpost to our performance then bring them on.
Ignoring a payment from GSK due to a patent dispute their results beat expectations.
We have a bit of a drift at the moment which is only to be expected after such a good run but nothing has changed. Can't wait for the trading update anytime after a week next Wednesday when the year is up.
Vectura shares will jump today maybe by as much as a £1.00 or even more. Means nothing if you have none. And whilst not expecting anything like this for Carclo hopefully we will get a good bounce. Jmo

Omega Diagnostics and Global Access Diagnostics are members of the UK Rapid Antigen Test Consortium, a growing coalition of industry scientists and manufacturers, who have come together to secure lateral flow tests and manufacturing capability for the UK.Professor Chris Molloy, Chair UK Rapid Antigen Test Consortium, said:The consortium has been harnessing the power of the UK Diagnostics industry since summer 2020 to significantly contribute to the national effort to ramp up and expand rapid regular testing programmes. We believe, these programmes, alongside vaccine roll-out, will be key for getting people back to work, education and friends and family.We have increased manufacturing capacity tenfold, and our member's tests continue to be validated and marketed. We have also started a digital arm comprised of digital solution providers to work with HMG and regulators on new technologies and standards moving forwards.Numerous bilateral deals have also been agreed between members as a result of industry coming together with intense purpose and leaving competition at the door in order to prioritise the generation of new UK tests and manufacture them at a scale never considered possible.We would like to take the time now to thank all those suppliers and manufacturers who have contributed their time and resources to this national effort. Our work here lays a strong foundation for how the diagnostics industry as a whole will flourish in the UK to improve our healthcare in the future. End.
Bodes well for CARCLO.

Thanks for the US perspective Buckhunter217. Its good to hear from you again.
Ps, don't spend it all at once??

Agree with Longterm and Wigwammer.
I dont think we have got going yet.
I wouldnt be surprised if in a full year we cant t/o £120/£130million given whats going on.
With lots of exceptionals now gone or at least much reduced and no longer top heavy we should be able to make somewhere around the £10million mark. Put us on a modest pe of 15 that gives us £150million. Take off debt say £30m and pension deficit of say £50m divide that by shares in issue and you get circa £1.00 per share. put us on a multiply of 30 (not out of the question in my opinion) that give us just over £3.00 per share. Hence imo why we have interest in the shares. jmo

Another good find Steelwatch.
I wonder if these are for use in the UK only?

If nothing before the year end, hopefully we will get an early (April) trading update!

Add your great post Steelwatch to Wigwammer's great news yesterday and we have a real recipe for a climb from here.
Trades are certainly picking up.
Jmo

/DUROC/Duroc has sold its holding in Carclo PlcEnglish

Duroc has sold its holding in Carclo Plc
FRI, FEB 26, 2021 16:35 CET

26 February 2021

Duroc has sold its entire holding in Carclo plc for SEK 25 million, and thereby reduced the group’s net debt. Prior to the sale, Duroc owned 13 percent of the shares in Carclo plc.

"As the development in the company did not live up to our expectations, we have decided to exit the investment," says Duroc's CEO John Häger.

The holding in Carclo has been valued at market value in Duroc's balance sheet and the change in value has been reported in other comprehensive income. The sale of the holding has a positive effect on equity of SEK 7.5 million in Duroc's third quarter.

I would think that is Duroc AB gone.
An RNS this evening would be great.
What a coinsidence ......our buyer (s) have snapped up the lot and loads more.
We should see good progress from here if I am correct.
jmo

Hopefully not boring folks to death, just that I am intrigued as to what is goin on.
Our normal trading pattern is a few hundred thousand shares a day on good days.
Now Duroc have sold ( Wed 15th & Thurs 16th) a further 2,493,922 shares.
Over those two days a total of £8,131,160 shares have been traded.
if this had happend without Durocs notice of sales everybody would be wondering what was going on.
My view (ever the conspiracy theorist) its too much of a coinsidence and hides the fact we have someone building a position in the company. That maybe just an investment or maybe something else??????? but its certainly with the knowledge (Broker) that a position in the company was becoming available. So far we have been told (historically) that Duroc has sold
some 4million shares and the price has held.
I believe interest will emerge in Carclo once the 6 months results are declared shpowing a growing business , reducing pension deficit and manageable debt.
The intrigue continues for now......

I did wonder.
My 1st thought was that it was an error and should read:
"our customer".
Interesting that two of us picked up on the wording .

If not something interesting afoot.
We got the notice of holdings on Thursday 18th.
Duroc on the 16th had reduced their holdings from 13.01% to 10.89%. They had sold some 1.559 million shares. The number of trades on 16th Tuesday was circa 2,540 million that was enough to cover the total amount leaving plenty excess for "ordinary shareholder" trades.
Then we have Wednesday, 3, 050,900 shares traded, Thursday, 5,080,260 shares traded and Friday 1,366,534. In total 9,5million shares traded we'd, thur, Fri.
If that is enough to take their 7.992,209 then maybe they are out.
I have only counted the shares traded on the LSE market not the EURO exchange.
My point is.
1. If they are out (Mon rns maybe) who is buying the shares?
2. If they are not out, where is the sudden ramp up and interest coming from.
It is good that after an institutional sale of some 2.12% of our companies shares we are still trading at a similiar price to last week. Jmo

I think to stock has held up very well.
We will no doubt get further notifications as thresholds are crossed. Who knows we may even get one from a buyer. We all know there are two sides to this bargin.
Let's hope whatever pans out , pans out quickly and sharply. Jmo

After this notification, if I am correct Duroc AB had 7,949,700 shares remaining.
The notice says:"Date on which threshold crossed or reached was Tuesday 16th".
Duroc AB could then have offloaded more yesterday and further more today.
Even if they have decided to offload their entire holding, at this rate they will finish early next week.
It is understandable that this company might want to sell. There are a miriad of reasons for a company wanting cash at this time. Really glad Carclo have only about 73million shares. JMO

Now we know who is reducing. I wonder at what level they will be happy to continue holding?

We didn't get a mention in the text but is nice to see both Eric Hutchinson and Frank Doorenbosch share purchases listed in today's FT.
There were only eight deals in total with two CARCLO.
I take note each week of the buys and sells, over the years have invested in a few, a couple of which have been gems.
Let's hope we get a handful of new investors next week.
Jmo

Phil White will be appointed as Chief Financial Officer and a Director of the Board with effect from 1st March.
The changes continue. Peter Slabbert will be stepping down from the board 31st March with his role filled by Eric Hutchinson.
Good to see Phil White stepping up rather than a complete new brush in this crucial role. Jmo

Sorry about the repeated message.
Thought I had lost the 1st.
Quickly re-typed and posted only now do I see the 1st just haden't loaded.